Anumigilimab

Tax included
Anumigilimab (CSL-324) is an humanized IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation.
MedChemExpress 
HY-P99440

Data sheet

Size
Multiple sizes
Reactivity
c-Fms
CAS
2416593-08-1